<html>
<head>PUBMED IDs for CD153</head>
<body bgcolor='#C5F0F2'><h1>CD153</h1><a href='https://pubmed.ncbi.nlm.nih.gov/9622100/'>Enhancement of antitumor immunity by expression of CD70 (CD27 ligand) or CD154 (CD40 ligand) costimulatory molecules in tumor cells.</a> June 11  1998<br><a href='https://pubmed.ncbi.nlm.nih.gov/10878352/'>Engagement of CD153 (CD30 ligand) by CD30+ T cells inhibits class switch DNA recombination and antibody production in human IgD+ IgM+ B cells.</a> July 6  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/12034885/'>Cowpox virus encodes a fifth member of the tumor necrosis factor receptor family: a soluble, secreted CD30 homologue.</a> May 30  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/12392508/'>Characterization of the murine CD30 ligand (CD153) gene: gene structure and expression.</a> October 24  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/12672812/'>Selective inhibition of class switching to IgG and IgE by recruitment of the HoxC4 and Oct-1 homeodomain proteins and Ku70/Ku86 to newly identified ATTT cis-elements.</a> April 4  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/16771849/'>Deciphering CD30 ligand biology and its role in humoral immunity.</a> June 15  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/24745678/'>CD30 in systemic mastocytosis.</a> January 23  2014<br></body></html>
